Nath Bio-Genes (India) (NATHBIOGEN) — Board Meeting

Nath Bio-Genes (India) Limited announced the outcome of its Board meeting on 4 May 2026, approving standalone and consolidated financial results for Q4 FY2026, recommending a final dividend of Rs 2 per share (20% of nominal value) subject to shareholder approval at the upcoming AGM, reappointing Independent Director Hitesh Rajnikant Purohit for a second term until 2032, appointing K.P. Sahasrabudhe & Co. as internal auditors for FY2026-27, and increasing Managing Director Satish Kagliwal's annual remuneration from Rs 66 lakh to Rs 1.44 crore effective 1 January 2026. The auditor issued an unmodified opinion on the financial statements, confirming compliance with Ind AS and effective internal controls, while highlighting unresolved recovery of Rs 600.73 Lakhs from doubtful farmer advances and pending confirmations for trade receivables/payables.

📄 View Original Announcement (PDF)

📊 Stock Analysis — NATHBIOGEN ✨ Ask AI About This

About Nath Bio-Genes (India) Limited (NATHBIOGEN)

Fast Moving Consumer Goods · FMCG · Listed on NSE

Market Cap: ₹289.43 Cr P/E: 7.8 ROE: 6.0% ROCE: 7.9% Div Yield: 1.31%

View full NATHBIOGEN stock details →

📡 Get AI alerts when NATHBIOGEN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NATHBIOGEN — Free

💡 Ask AI about this filing

"How does this board meeting affect Nath Bio-Genes (India) Limited's outlook?" "What did Nath Bio-Genes (India) Limited announce on 4 May 2026?" "Is this positive or negative for NATHBIOGEN?"

Ask AI Free →

📊 More NATHBIOGEN filings

See all NATHBIOGEN filings →

🔥 Also filed on 4 May 2026

PREMIERENE Premier Energies Limited Corporate Action PREMIERENE Premier Energies Limited Corporate Action PREMIERPOL Premier Polyfilm Limited Insider Trading PURVA Puravankara Limited Announcement PVRINOX PVR INOX Limited Financial Results PVSL Popular Vehicles and Services Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NATHBIOGEN files new disclosures

Track NATHBIOGEN filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track NATHBIOGEN — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd